|Articles|March 1, 1996

March 1996
Volume 2
Issue 3

Ideas and Initiatives in the Managed Care Marketplace

Author(s)Craig S. Stern, RPh, PharmD

Download PDF: Ideas and Initiatives in the Managed Care Marketplace

Articles in this issue

over 30 years ago

Article

Managed Care Outcomes Project: Study Design, Baseline Patient Characteristics, and Outcome Measures

over 30 years ago

Article

Intended and Unintended Consequences of HMO Cost-Containment Strategies: Results from the Managed Care Outcomes Project

over 30 years ago

Article

The National Clinics Research Consortium's (NCRC) Use of Administrative Databases for Collaborative Study: The Case of Prostatectomy

over 30 years ago

Article

Cost-Effectiveness of Chiropractic Care in a Managed Care Setting

over 30 years ago

Article

Can We Continue to Afford Organ Transplants in an Era of Managed Care?

over 30 years ago

Article

The Costs of Allergic Rhinitis

over 30 years ago

Article

PACE: Managed Care for the Frail Elderly

over 30 years ago

Article

The Impact of Managed Care on Community Psychiatry

over 30 years ago

Article

Managed Care Cost Containment and the Law of Unintended Consequences

over 30 years ago

Article

Correspondence regarding, "Cost Benefit Analysis of Epilepsy Treatment by the Neurologist"

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Ideas and Initiatives in the Managed Care Marketplace

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies